We are live on ! Find out more
HUMA icon

Humacyte

123 hedge funds and large institutions have $150M invested in Humacyte in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 14

171% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 17

107% more capital invested

Capital invested by funds: $72.4M → $150M (+$77.4M)

28% more funds holding

Funds holding: 96123 (+27)

6.3% more ownership

Funds ownership: 19.91%26.2% (+6.3%)

8% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $3.61M

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
123
Holders Change
+27
Holders Change %
+28.13%
% of All Funds
1.78%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
46
Increased
51
Reduced
14
Closed
17
Calls
$3.34M
Puts
$3.61M
Net Calls
-$272K
Net Calls Change
+$483K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$975K +$327K +62,800 +45%
Wellington Management Group
27
Wellington Management Group
Massachusetts
$933K -$19.5K -3,740 -2%
JF
28
Jump Financial
Illinois
$769K +$834K +160,297 New
Prudential Financial
29
Prudential Financial
New Jersey
$755K +$819K +157,305 New
UBS Group
30
UBS Group
Switzerland
$594K +$154K +29,618 +31%
AIP
31
ARS Investment Partners
New York
$559K +$606K +116,419 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$532K +$270K +51,858 +88%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$501K +$543K +104,296 New
VF
34
Virtu Financial
New York
$495K +$207K +39,760 +63%
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$495K +$513K +98,601 New
EGM
36
Engineers Gate Manager
New York
$483K +$523K +100,560 New
EWM
37
Endowment Wealth Management
Wisconsin
$482K +$15.6K +3,000 +3%
AllianceBernstein
38
AllianceBernstein
Tennessee
$457K +$260K +49,980 +110%
Barclays
39
Barclays
United Kingdom
$409K +$95.3K +18,319 +27%
Fidelity Investments
40
Fidelity Investments
Massachusetts
$353K +$372K +71,494 +3,642%
Simplex Trading
41
Simplex Trading
Illinois
$331K +$201K +38,605 +127%
Squarepoint
42
Squarepoint
New York
$328K -$123K -23,661 -26%
MIM
43
MetLife Investment Management
New Jersey
$251K +$95.2K +18,301 +54%
JP Morgan Chase
44
JP Morgan Chase
New York
$251K +$22.7K +4,360 +9%
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$249K -$37.5K -7,209 -12%
Osaic Holdings
46
Osaic Holdings
Arizona
$243K +$18K +3,455 +7%
AFM
47
Anson Funds Management
Texas
$240K
CF
48
Corebridge Financial
Texas
$227K +$246K +47,291 New
Citadel Advisors
49
Citadel Advisors
Florida
$211K -$1.09M -210,349 -83%
Wolverine Trading
50
Wolverine Trading
Illinois
$192K +$110K +21,068 +111%

HUMA Hedge Fund Activity: Q2 2024 in Review

123 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2024, worth a combined $150M — up 107% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new HUMA positions and 17 closed out — a net gain of 29 holders — while 51 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.71M sold.

  • 123 institutional investors held Humacyte (HUMA) as of Q2 2024, up from 96 in Q1 2024.
  • Funds reported $150M of Humacyte stock for Q2 2024, up 107% quarter-over-quarter.
  • 46 funds opened new Humacyte positions in Q2 2024 and 17 closed out, a net change of +29 holders.
  • The largest Humacyte buyer in Q2 2024 was BlackRock, an estimated $12.2M added.
  • The largest Humacyte seller in Q2 2024 was AIGH Capital Management, an estimated $6.71M sold.

Based on aggregated 13F filings for Q2 2024.